An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE)
NCT ID: NCT01609075
Last Updated: 2016-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
437 participants
OBSERVATIONAL
2012-06-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Metastatic colorectal cancer
* Having initiated first-line treatment with fluoropyrimidine-based chemotherapy plus Avastin between 1. September 2011 and 29. February 2012
* Availability of test fro K-RAS genotyping
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
L’Aquila, Abruzzo, Italy
Teramo, Abruzzo, Italy
Brindisi, Apulia, Italy
Castellana Grotte (BA), Apulia, Italy
Foggia, Apulia, Italy
Lecce, Apulia, Italy
San Giovanni Rotondo, Apulia, Italy
Rionero in Vulture, Basilicate, Italy
Cosenza, Calabria, Italy
Lamezia Terme (CZ), Calabria, Italy
Reggio Calabria, Calabria, Italy
Benevento, Campania, Italy
Napoli, Campania, Italy
Napoli, Campania, Italy
Pagani ( Sa), Campania, Italy
Imola (BO), Emilia-Romagna, Italy
Modena, Emilia-Romagna, Italy
Parma, Emilia-Romagna, Italy
Pordenone, Friuli Venezia Giulia, Italy
Albano Laziale, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Sora, Lazio, Italy
Viterbo, Lazio, Italy
Genoa, Liguria, Italy
La Spezia, Liguria, Italy
Savona, Liguria, Italy
Bergamo, Lombardy, Italy
Brescia, Lombardy, Italy
Cremona, Lombardy, Italy
Lecco, Lombardy, Italy
Milan, Lombardy, Italy
Milan, Lombardy, Italy
Monza, Lombardy, Italy
Pavia, Lombardy, Italy
S. Fermo Della Battaglia (CO), Lombardy, Italy
Saronno, Lombardy, Italy
Varese, Lombardy, Italy
Cuneo, Piedmont, Italy
Novara, Piedmont, Italy
Orbassano, Piedmont, Italy
Ponderano (BI), Piedmont, Italy
Turin, Piedmont, Italy
Turin, Piedmont, Italy
Cagliari, Sardinia, Italy
Sassari, Sardinia, Italy
Catania, Sicily, Italy
Cefalù, Sicily, Italy
Messina, Sicily, Italy
Messina, Sicily, Italy
Palermo, Sicily, Italy
Taormina, Sicily, Italy
Vimercate, Sicily, Italy
Fano, The Marches, Italy
Fermo, The Marches, Italy
Macerata, The Marches, Italy
Grosseto, Tuscany, Italy
Lido di Camaiore, Tuscany, Italy
Livorno, Tuscany, Italy
Pontedera, Tuscany, Italy
Siena, Tuscany, Italy
Perugia, Umbria, Italy
Cona (Ferrara), Veneto, Italy
Este, Veneto, Italy
Este (PD), Veneto, Italy
Mirano, Veneto, Italy
Montecchio Maggiore, Veneto, Italy
Padua, Veneto, Italy
Rovigo, Veneto, Italy
Treviso, Veneto, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lonardi S, Nasti G, Fagnani D, Gemma D, Ciuffreda L, Granetto C, Lucchesi S, Ballestrero A, Biglietto M, Proserpio I, Bergamo F, Proietti E, Tonini G. Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study. Tumori. 2019 Jun;105(3):243-252. doi: 10.1177/0300891619834126. Epub 2019 Mar 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML27907
Identifier Type: -
Identifier Source: org_study_id